Page 12 – Clinical Laboratory int.

Astoriom forges strategic alliance with Carolina Molecular to streamline biospecimen workflows

, 26 September 2025/in E-News /by panglobal

Research Triangle Park, North Carolina, United States, has witnessed a significant consolidation of molecular testing and biospecimen storage services as Astoriom and Carolina Molecular announce a strategic partnership designed to address critical workflow challenges in clinical research operations.

ARTCLINE secures €5 million to advance septic shock immunotherapy

, 26 September 2025/in E-News /by panglobal

German biomedical company ARTCLINE has closed a €5 million convertible loan financing round to complete its ongoing ReActIF-ICE clinical trial evaluating the ARTICE® extracorporeal therapy. The treatment uses allogeneic immune cells from healthy donors to support dysregulated immune systems in septic shock patients.

Multi-omics study identifies protein biomarkers and potential drug targets to improve psoriatic arthritis diagnosis and treatment

, 26 September 2025/in Featured Articles, Protein Analysis, Proteomics & Mass Spectrometry /by panglobal

Background Psoriatic arthritis (PsA) has a global incidence of approximately 0.1–0.2% and affects men and women equally. PsA is a chronic, immune-mediated, inflammatory disease, closely linked to psoriasis. Whereas psoriasis is characterized by patches of abnormal skin, PsA affects the joints and often includes damage to the fingernails and or toenails. Around 30% of people […]

Therapeutic drug monitoring in autoimmune and oncological diseases

, 26 September 2025/in Featured Articles, Therapeutic Drug Monitoring /by panglobal

by Dr Jacqueline Gosink Therapeutic drug monitoring (TDM) supports optimized use of biologic therapies in the treatment of immune-mediated inflammatory diseases and some cancers. By guiding clinical decision-making on individualized dosage, treatment intervals or the need to switch therapies, TDM contributes to improved patient outcomes. Circulating drug concentrations and anti-drug antibody levels can be measured […]

The rise of interest in detection of respiratory syncytial virus

, 26 September 2025/in Featured Articles /by panglobal

Respiratory syncytial virus has come under the spotlight in recent years for a number of reasons. CLI chatted to Dr Adam Meijer (Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands) to find out more about why interest in detection of this virus has increased.

Radiometer to showcase blood gas analysers at IBMS Congress

, 8 September 2025/in Product News /by panglobal

Radiometer, the urgent and acute care testing specialist, will join forces with Leica Biosystems and Cepheid to present a unified Danaher Diagnostics portfolio at IBMS Congress 2025. The collaboration, to be showcased on Stand 109 at Birmingham ICC from 22-25 September, demonstrates how point-of-care (POC) blood gas and immunoassay analysers can create a more connected […]

Natera launches Fetal Focus for inherited condition screening

, 27 August 2025/in Product News /by panglobal

Natera has launched Fetal Focus™, a pioneering noninvasive prenatal test (NIPT) that screens for inherited conditions directly from maternal blood samples. This innovative diagnostic addresses a critical clinical gap when biological fathers are unavailable for carrier screening, transforming prenatal genetic testing capabilities.

Bio-Rad launches StarBright UltraViolet700 dye for spectral flow

, 27 August 2025/in Product News /by panglobal

Bio-Rad Laboratories has expanded its StarBright fluorescent dye portfolio with the introduction of StarBright UltraViolet700 (SBUV700), specifically engineered for spectral flow cytometry applications in immunology research. The new dye represents the first in a planned series rollout over the coming months, targeting enhanced panel design capabilities for clinical laboratories and research institutions.